服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Type | Clone No |
| Anti-ITGA4B7 and ITGAEB7 mAbs [Etrolizumab Biosimilar] (MABL-4685) | MABL-4685 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ENTPD1/CD39 mAbs [Eurestobart Biosimilar] (MABL-4686) | MABL-4686 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CTLA4/CD152 mAbs [Evalstotug Biosimilar] (MABL-4687) | MABL-4687 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ANGPTL3 mAbs [Evinacumab Biosimilar] (MABL-4688) | MABL-4688 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PCSK9 mAbs [Evolocumab Biosimilar] (MABL-4689) | MABL-4689 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-TNFRSF9/CD137/4-1BB mAbs [Evunzekibart Biosimilar] (MABL-4690) | MABL-4690 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-Hepatitis B Surface Antigen mAbs [Exbivirumab Biosimilar] (MABL-4691) | MABL-4691 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-TMPRSS6/MT2 mAbs [Exerenibart Biosimilar] (MABL-4692) | MABL-4692 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SNCA/PARK1/PARK4 mAbs [Exidavnemab Biosimilar] (MABL-4693) | MABL-4693 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDL1/CD274 mAbs [Envafolimab Biosimilar] (MABL-4664) | MABL-4664 | ELISA, FACS, Functional assay, in vivo binding | G1, na |
| Anti-CCR8/CKR-L1/CDw198 mAbs [Enzelkitug Biosimilar] (MABL-4665) | MABL-4665 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SIRPA mAbs [Epacmarstobart Biosimilar] (MABL-4666) | MABL-4666 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E;MS4A1/CD20 mAbs [Epcoritamab Biosimilar] (MABL-4667) | MABL-4667 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Lambda;Kappa |
| Anti-SIGLEC2/CD22 mAbs [Epratuzumab Biosimilar] (MABL-4668) | MABL-4668 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CALCA and CALCB mAbs [Eptinezumab Biosimilar] (MABL-4669) | MABL-4669 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NCR3LG1/B7-H6;CD3E mAbs [Etuptamig Biosimilar] (MABL-4670) | MABL-4670 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-MS4A1/CD20 mAbs [Eramkafusp Biosimilar] (MABL-4671) | MABL-4671 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CALCRL mAbs [Erenumab Biosimilar] (MABL-4672) | MABL-4672 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-PDL1/CD274;CTLA4/CD152 mAbs [Erfonrilimab Biosimilar] (MABL-4673) | MABL-4673 | ELISA, FACS, Functional assay, in vivo binding | G1, na;na |
| Anti-ITGB2/CD18 mAbs [Erlizumab Biosimilar] (MABL-4674) | MABL-4674 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn